TIS tissue therapies limited

request for broker & media coverage, page-3

  1. 1,130 Posts.
    lightbulb Created with Sketch. 1876
    Ash, you make the case very well with your excellent 7 points. I agree, encouraging more well informed coverage can only help everyone. The Channel 10 news coverage was a great start.

    The only additional points I would add for brokers would be something along the lines of:

    8. It is very rare to have the opportunity in Australia to get in on the ground floor for a company about to launch such a great product internationally - a product that will prevent countless leg amputations around the world.

    9. After a recent successful capital raising, TIS is cashed up for manufacturing VitroGro, and should not need to raise any more capital, providing they conclude a partner deal this year as expected.

    Once again, well done!
    Cheers

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.